MedPath
NMPA Approval

Hymecromone Capsules

国药准字H44021833

December 5, 2019

Drug Information

羟甲香豆素胶囊

胶囊剂

0.4g

化学药品

December 5, 2019

Company Information

Applicant Company

Manufacturing Company

广东省肇庆市前沙街103号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

羟甲香豆素胶囊 - NMPA 批准文号 | MedPath